NCT04760431 2021-06-02
TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Unknown
Second Affiliated Hospital, School of Medicine, Zhejiang University
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)